Systems biomarker characteristics of circulating alkaline phosphatase activities for 48 types of human diseases. (1st February 2022)

• Record Type: Journal Article
• Authors: Su, Wenhao; Qiu, Tong; Zhang, Meng; Hao, Cui; Zeng, Pengjiao; Huang, Zhangfeng; Du, Wenxing; Yun, Tianxiang; Xuan, Yunpeng; Zhang, Lijuan; Guo, Yachong; Jiao, Wenjie
• Is Part Of: Current medical research and opinion. Volume 38:Number 2(2022)
• Page Start: 201
• Page End: 209
• Publication Date: 2022-02-01
• Subjects: Systems biomarker -- alkaline phosphatase -- area under the curve (AUC) -- receiving operator curve (ROC) -- accuracy -- sensitivity -- specificity; Clinical medicine -- Periodicals; Therapeutics -- Periodicals; 615.5
• DOI: 10.1080/03007995.2021.2000715
• Languages: English
• ISSNs: 0300-7995

Abstract

Abstract: Background: Most human diseases are accompanied by systems changes. Systems biomarkers should reflect such changes. The phosphorylation and dephosphorylation of biomolecules maintain human homeostasis. However, the systems biomarker characteristics of circulating alkaline phosphatase, a routine blood test conducted for many human diseases, have never been investigated. Method: This study retrieved the circulating alkaline phosphatase (ALP) activities from patients with 48 clinically confirmed diseases and healthy individuals from the database of our hospital during the past five years. A detailed analysis of the statistical characteristics of ALP was conducted, including quantiles, receiving operator curve (ROC), and principal component analysis. Results: Among the 48 diseases, 45 had increased, and three had decreased median levels of ALP activities compared to the healthy control. Preeclampsia, hepatic encephalopathy, pancreatic cancer, and liver cancer had the highest median values, whereas nephrotic syndrome, lupus erythematosus, and nephritis had decreased median values compared to the healthy control. Further, area under curve (AUC) values were ranged between 0.61 and 0.87 for 19 diseases, and the ALP activities were the best systems biomarker for preeclampsia (AUC 0.87), hepatic encephalopathy (AUC 0.87), liver cancer (AUC 0.81), and pancreatic cancer (AUC 0.81). Conclusions: Alkaline phosphatase was a decent systems biomarker for 19 different types of human diseases. Understanding the molecular mechanisms of over-up-and-down-regulation of ALP activities might be the key to understanding the whole-body systems' reactions during specific disease progression.